Sign in

CIK 0001582554

  • Non-accelerated filer
  • Smaller reporting company

Matinas BioPharma Holdings, Inc.

Sign in to watch
Ticker
MTNB
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463011414
Phone
+1 908-484-8805
Business address
1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
  1. 4 Grant or award Director acquired 31,579 shares (grant or award)
  2. 4 Grant or award Director acquired 11,760 shares (grant or award)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Gift Director gave 750,000 shares (gift)
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market buy Chief Scientific Officer bought 5,000 shares at $1.41 ($7,050)
  10. 4 Open-market buy Director bought 100,000 shares at $1.38 ($138,000)
  11. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $1.36 ($6,800)
  12. 4 Open-market buy Director bought 5,000 shares at $1.24 ($6,200)
  13. 4 Open-market buy Director bought 100,000 shares at $1.30 ($130,000)
  14. 4 Open-market buy Director bought 5,000 shares at $1.29 ($6,450)
  15. 4/A Derivatives Options or other derivatives
  16. 4 Other disposition Shareholder disposed of 10,496,760 shares (other)
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 11 of 12 · 232 filings